By ClearSight Therapeutics, Inc. Proposed five-year agreement positions Covalent Medical to commercialize ClearSight's OTC Artificial Tears+, Contact Lens Rewetting Drops, and Pink Eye portfolio across physician-dispensed and national retail channels, with launch targeted for Q1 2027...
|
 | By PebblePad PebblePad, the ePortfolio, workbook, and assessment platform for Higher Education, is proud to announce a strategic partnership with Inside Higher Ed (IHE) and Times Higher Education (THE), two leading voices in global higher education.
|
